Athersys, Inc. (ATHXQ)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 28, 2026, 9:30 AM EST
9,900%
Market Cap 62.00
Revenue (ttm) 80.00K
Net Income (ttm) -37.51M
Shares Out 61.75M
EPS (ttm) -1.89
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 7,351
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range n/a
Beta 56.20
RSI 64.30
Earnings Date n/a

About Athersys

Athersys, Inc., a clinical-stage biotechnology company, develops therapies in the regenerative medicine area. Its stem cell product candidate is the MultiStem cell therapy, an allogeneic stem cell product for the treatment of indications in the neurological, inflammatory and immune, and cardiovascular disease areas, as well as other critical care conditions. The company was founded in 1995 and is headquartered in Cleveland, Ohio. On September 24, 2024, the voluntary petition of Athersys, Inc. for reorganization under Chapter 11 was converted to... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1995
Employees 24
Stock Exchange OTCMKTS
Ticker Symbol ATHXQ
Full Company Profile

Financial Performance

In 2022, Athersys's revenue was $5.33 million, a decrease of -3.43% compared to the previous year's $5.51 million. Losses were -$72.53 million, -16.58% less than in 2021.

News

Athersys Transcript: Investor Update

2 years ago - Transcripts

Athersys Transcript: Status Update

3 years ago - Transcripts

Athersys Transcript: Investor Update

3 years ago - Transcripts

Athersys Transcript: Status Update

3 years ago - Transcripts

Athersys Transcript: Study Result

3 years ago - Transcripts

Athersys Transcript: Status Update

4 years ago - Transcripts

Athersys Transcript: Status Update

4 years ago - Transcripts

Athersys Transcript: Status Update

4 years ago - Transcripts